Stock Track | 10x Genomics Plummet 5.01% Intraday as Life Sciences Sector Slides Ahead of Earnings

Stock Track08-07

Shares of 10x Genomics, Inc. (TXG) plummeted 5.01% during intraday trading on Thursday, as the stock came under significant selling pressure amid a broader downturn in the Life Sciences Tools & Services sector.

The decline occurred ahead of the company's highly anticipated second-quarter earnings report, which was scheduled for release after the market close. The selloff was not isolated to 10x Genomics; peer Illumina notably fell 5.67% on the same day, while other sector heavyweights such as Thermo Fisher Scientific, Danaher, and IQVIA also posted losses. The broad-based weakness suggests that investors were reducing exposure to the sector ahead of key earnings catalysts.

Market consensus for the upcoming report had projected quarterly revenue of approximately $147 million, representing a 5.28% year-over-year increase, and an adjusted loss per share of $0.24. The company had previously beaten first-quarter estimates, but the overall cautious sentiment and sector-wide pressure weighed on the stock in the session.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1157212866?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-08-07 00:24","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1157212866","market":"nz","top_or_hot":-1,"title":"Stock Track | 10x Genomics Plummet 5.01% Intraday as Life Sciences Sector Slides Ahead of Earnings","media":"Stock Track","content":"<p>Shares of 10x Genomics, Inc. (TXG) plummeted 5.01% during intraday trading on Thursday, as the stock came under significant selling pressure amid a broader downturn in the Life Sciences Tools & Services sector.</p><p>The decline occurred ahead of the company's highly anticipated second-quarter earnings report, which was scheduled for release after the market close. The selloff was not isolated to 10x Genomics; peer Illumina notably fell 5.67% on the same day, while other sector heavyweights such as Thermo Fisher Scientific, Danaher, and IQVIA also posted losses. The broad-based weakness suggests that investors were reducing exposure to the sector ahead of key earnings catalysts.</p><p>Market consensus for the upcoming report had projected quarterly revenue of approximately $147 million, representing a 5.28% year-over-year increase, and an adjusted loss per share of $0.24. The company had previously beaten first-quarter estimates, but the overall cautious sentiment and sector-wide pressure weighed on the stock in the session.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | 10x Genomics Plummet 5.01% Intraday as Life Sciences Sector Slides Ahead of Earnings</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | 10x Genomics Plummet 5.01% Intraday as Life Sciences Sector Slides Ahead of Earnings\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time\">2026-08-07 00:24</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Shares of 10x Genomics, Inc. (TXG) plummeted 5.01% during intraday trading on Thursday, as the stock came under significant selling pressure amid a broader downturn in the Life Sciences Tools & Services sector.</p><p>The decline occurred ahead of the company's highly anticipated second-quarter earnings report, which was scheduled for release after the market close. The selloff was not isolated to 10x Genomics; peer Illumina notably fell 5.67% on the same day, while other sector heavyweights such as Thermo Fisher Scientific, Danaher, and IQVIA also posted losses. The broad-based weakness suggests that investors were reducing exposure to the sector ahead of key earnings catalysts.</p><p>Market consensus for the upcoming report had projected quarterly revenue of approximately $147 million, representing a 5.28% year-over-year increase, and an adjusted loss per share of $0.24. The company had previously beaten first-quarter estimates, but the overall cautious sentiment and sector-wide pressure weighed on the stock in the session.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"TXG","symbol_name":"10x Genomics, Inc.","start_time":0,"source_url":"","article_id":"1157212866","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1157212866","pubTimestamp":1786033459,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"Shares of 10x Genomics, Inc. (TXG) plummeted 5.01% during intraday trading on Thursday, as the stock came under significant selling pressure amid a broader downturn in the Life Sciences Tools &...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"TXG":"10x Genomics, Inc."},"translate_title":"股票跟踪 | 生命科学板块盈利前下滑，10x Genomics 盘中暴跌 5.01%","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"TXG":1},"content_text":"Shares of 10x Genomics, Inc. (TXG) plummeted 5.01% during intraday trading on Thursday, as the stock came under significant selling pressure amid a broader downturn in the Life Sciences Tools & Services sector.The decline occurred ahead of the company's highly anticipated second-quarter earnings report, which was scheduled for release after the market close. The selloff was not isolated to 10x Genomics; peer Illumina notably fell 5.67% on the same day, while other sector heavyweights such as Thermo Fisher Scientific, Danaher, and IQVIA also posted losses. The broad-based weakness suggests that investors were reducing exposure to the sector ahead of key earnings catalysts.Market consensus for the upcoming report had projected quarterly revenue of approximately $147 million, representing a 5.28% year-over-year increase, and an adjusted loss per share of $0.24. The company had previously beaten first-quarter estimates, but the overall cautious sentiment and sector-wide pressure weighed on the stock in the session.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"-1","news_tag":"movement","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.47.1","shortVersion":"4.47.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1157212866","isCrawlerRequest":true}